{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T22:18:19Z","timestamp":1794694699242,"version":"4.9.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,3,24]],"date-time":"2023-03-24T00:00:00Z","timestamp":1679616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,24]],"date-time":"2023-03-24T00:00:00Z","timestamp":1679616000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Expo Sci Environ Epidemiol"],"published-print":{"date-parts":[[2023,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Per- and polyfluoroalkyl substances (PFAS) have been suggested to contribute to the development of metabolic diseases such as obesity, diabetes and non-alcoholic fatty liver disease (NAFLD). However, evidence from epidemiological studies remain divergent.\u00a0The aim of the present study was to evaluate associations between PFAS exposure and prevalent diabetes in a cross-sectional analysis and fasting glucose in a longitudinal analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      In 2373 subjects aged 45\u201375 years from the EpiHealth study, three PFAS; perfluorohexanesulfonic acid (PFHxS), perfluorooctanoic acid (PFOA) and perfluorooctane sulfonic acid (PFOS) were analyzed in plasma together with information on prevalent diabetes. Participants in the PIVUS study (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20091016 at baseline, all aged 70 years) were followed over 10 years regarding changes in plasma levels of six PFAS; PFHxS, PFOA, PFOS, perfluorononanoic acid (PFNA), perfluorodecanoic acid (PFDA), and perfluoroundecanoic acid (PFUnDA), and changes in plasma levels of fasting glucose.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In the EpiHealth study, no overall associations could be observed between the levels of PFOA, PFOS or PFHxS and prevalent diabetes. However, there was a significant sex-interaction for PFOA (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.02), and an inverse association could be seen between PFOA (on a SD-scale) and prevalent diabetes in women only (OR: 0.71, 95%\u2009CI: 0.52, 0.96,\n                      <jats:italic>p<\/jats:italic>\n                      -value: 0.02). This association showed a non-monotonic dose-response curve. In the PIVUS study, inverse relationships could be observed between the changes in levels (ln-transformed) of PFOA and PFUnDA vs the change in fasting glucose levels (ln-transformed) over 10 years (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.04 and\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.02, respectively). As in EpiHealth, these inverse associations were significant only in women (PFOA: \u03b2: \u22120.03,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.02, PFUnDA: \u03b2: \u22120.03,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.03).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Impact<\/jats:title>\n                    <jats:p>\n                      Exposure to per- and polyfluoroalkyl substances (PFAS) has been linked to unfavorable human health, including metabolic disorders such as obesity, diabetes and non-alcoholic fatty liver disease. However, results from in vivo, in vitro and epidemiological studies are incoherent. The aim of the present study was therefore to investigate associations between PFAS and diabetes in a cross-sectional study and glucose levels in a longitudinal study. Results show inverse associations in women only. Results also display non-monotonic dose response curves (\n                      <jats:italic>i.e<\/jats:italic>\n                      ., that only low levels of PFOA are related to higher probability of prevalent diabetes). This suggests that sex differences and complex molecular mechanisms may underlie the observed findings. A better understanding of the factors and molecular mechanisms contributing to such differences is recognized as an important direction for future research.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>PFOA was found to be inversely related to both prevalent diabetes and changes in plasma glucose levels among women only. Thus, our findings suggest there are sex differences in the inverse relationship of PFOA and type 2 diabetes and glucose levels.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1038\/s41370-023-00529-x","type":"journal-article","created":{"date-parts":[[2023,3,24]],"date-time":"2023-03-24T15:04:13Z","timestamp":1679670253000},"page":"748-756","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Associations between per- and polyfluoroalkyl substances (PFAS) and diabetes in two population-based cohort studies from Sweden"],"prefix":"10.1038","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9288-7942","authenticated-orcid":false,"given":"Linda","family":"Dunder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samira","family":"Salihovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f6lve","family":"Elmst\u00e5hl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. Monica","family":"Lind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Lind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,24]]},"reference":[{"key":"529_CR1","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1039\/D0EM00291G","volume":"22","author":"J Gl\u00fcge","year":"2020","unstructured":"Gl\u00fcge J, Scheringer M, Cousins IT, DeWitt JC, Goldenman G, Herzke D. et al. An overview of the uses of per- and polyfluoroalkyl substances (PFAS). Environ Sci Process Impacts. 2020;22:2345\u201373. https:\/\/doi.org\/10.1039\/D0EM00291G.","journal-title":"Environ Sci Process Impacts"},{"key":"529_CR2","doi-asserted-by":"publisher","first-page":"106123","DOI":"10.1016\/j.envint.2020.106123","volume":"145","author":"B G\u00f6ckener","year":"2020","unstructured":"G\u00f6ckener B, Weber T, R\u00fcdel H, B\u00fccking M, Kolossa-Gehring M. Human biomonitoring of per- and polyfluoroalkyl substances in German blood plasma samples from 1982 to 2019. Environ Int. 2020;145:106123 https:\/\/doi.org\/10.1016\/j.envint.2020.106123.","journal-title":"Environ Int"},{"key":"529_CR3","doi-asserted-by":"publisher","first-page":"107068","DOI":"10.1016\/j.envint.2021.107068","volume":"160","author":"I van Beijsterveldt","year":"2022","unstructured":"van Beijsterveldt I, van Zelst BD, van den Berg SAA, de Fluiter KS, van der Steen M, Hokken-Koelega ACS. Longitudinal poly- and perfluoroalkyl substances (PFAS) levels in Dutch infants. Environ Int. 2022;160:107068. https:\/\/doi.org\/10.1016\/j.envint.2021.107068.","journal-title":"Environ Int"},{"key":"529_CR4","doi-asserted-by":"publisher","first-page":"113902","DOI":"10.1016\/j.ijheh.2021.113902.","volume":"240","author":"M Liu","year":"2022","unstructured":"Liu M, Nordstrom M, Forand S, Lewis-Michl E, Wattigney WA, Kannan K, et al. Assessing exposures to per- and polyfluoroalkyl substances in two populations of great lakes basin fish consumers in Western New York state. Int J Hyg Environ Health. 2022;240:113902. https:\/\/doi.org\/10.1016\/j.ijheh.2021.113902.","journal-title":"Int J Hyg Environ Health"},{"key":"529_CR5","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1289\/ehp.10009.","volume":"115","author":"GW Olsen","year":"2007","unstructured":"Olsen GW, Burris JM, Ehresman DJ, Froehlich JW, Seacat AM, Butenhoff JL, et al. Half-life of serum elimination of perfluorooctanesulfonate,perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical production workers. Environ Health Perspect. 2007;115:1298\u2013305. https:\/\/doi.org\/10.1289\/ehp.10009.","journal-title":"Environ Health Perspect"},{"key":"529_CR6","doi-asserted-by":"publisher","first-page":"106333","DOI":"10.1016\/j.envint.2020.106333.","volume":"147","author":"Y Xu","year":"2021","unstructured":"Xu Y, Nielsen C, Li Y, Hammarstrand S, Andersson EM, Li H, et al. Serum perfluoroalkyl substances in residents following long-term drinking water contamination from firefighting foam in Ronneby, Sweden. Environ Int. 2021;147:106333. https:\/\/doi.org\/10.1016\/j.envint.2020.106333.","journal-title":"Environ Int"},{"key":"529_CR7","doi-asserted-by":"publisher","first-page":"27007","DOI":"10.1289\/ehp5337.","volume":"128","author":"G Pitter","year":"2020","unstructured":"Pitter G, Da Re F, Canova C, Barbieri G, Zare Jeddi M, Dapr\u00e0 F, et al. Serum levels of perfluoroalkyl substances (PFAS) in adolescents and young adults exposed to contaminated drinking water in the veneto region, Italy: a cross-sectional study based on a health surveillance program. Environ Health Perspect. 2020;128:27007. https:\/\/doi.org\/10.1289\/ehp5337.","journal-title":"Environ Health Perspect"},{"key":"529_CR8","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.envres.2017.07.050.","volume":"159","author":"J Stubleski","year":"2017","unstructured":"Stubleski J, Salihovic S, Lind PM, Lind L, Dunder L, McCleaf P, et al. The effect of drinking water contaminated with perfluoroalkyl substances on a 10-year longitudinal trend of plasma levels in an elderly Uppsala cohort. Environ Res. 2017;159:95\u2013102. https:\/\/doi.org\/10.1016\/j.envres.2017.07.050.","journal-title":"Environ Res"},{"key":"529_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/srep11029.","volume":"5","author":"S Yan","year":"2015","unstructured":"Yan S, Zhang H, Zheng F, Sheng N, Guo X, Dai J. Perfluorooctanoic acid exposure for 28 days affects glucose homeostasis and induces insulin hypersensitivity in mice. Sci Rep. 2015;5:11029 https:\/\/doi.org\/10.1038\/srep11029.","journal-title":"Sci Rep"},{"key":"529_CR10","doi-asserted-by":"publisher","first-page":"e87137","DOI":"10.1371\/journal.pone.0087137.","volume":"9","author":"HT Wan","year":"2014","unstructured":"Wan HT, Zhao YG, Leung PY, Wong CK. Perinatal exposure to perfluorooctane sulfonate affects glucose metabolism in adult offspring. PloS One. 2014;9:e87137 https:\/\/doi.org\/10.1371\/journal.pone.0087137.","journal-title":"PloS One"},{"key":"529_CR11","doi-asserted-by":"publisher","first-page":"3428","DOI":"10.1021\/acs.est.9b07295.","volume":"54","author":"WP Qin","year":"2020","unstructured":"Qin WP, Cao LY, Li CH, Guo LH, Colbourne J, Ren XM. Perfluoroalkyl substances stimulate insulin secretion by Islet \u03b2 cells via G protein-coupled receptor 40. Environ Sci Technol. 2020;54:3428\u201336. https:\/\/doi.org\/10.1021\/acs.est.9b07295.","journal-title":"Environ Sci Technol"},{"key":"529_CR12","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3390\/jox11030008.","volume":"11","author":"R Margolis","year":"2021","unstructured":"Margolis R, Sant KE. Associations between exposures to perfluoroalkyl substances and diabetes, hyperglycemia, or insulin resistance: a scoping review. J Xenobiotics. 2021;11:115\u201329. https:\/\/doi.org\/10.3390\/jox11030008.","journal-title":"J Xenobiotics"},{"key":"529_CR13","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s10654-013-9787-x.","volume":"28","author":"L Lind","year":"2013","unstructured":"Lind L, Elmst\u00e5hl S, Bergman E, Englund M, Lindberg E, Michaelsson K, et al. EpiHealth: a large population-based cohort study for investigation of gene-lifestyle interactions in the pathogenesis of common diseases. Eur J Epidemiol. 2013;28:189\u201397. https:\/\/doi.org\/10.1007\/s10654-013-9787-x.","journal-title":"Eur J Epidemiol"},{"key":"529_CR14","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.1161\/01.ATV.0000184769.22061.","volume":"25","author":"L Lind","year":"2005","unstructured":"Lind L, Fors N, Hall J, Marttala K, Stenborg A. A comparison of three different methods to evaluate endothelium-dependent vasodilation in the elderly. Arterioscler Thromb Vasc Biol. 2005;25:2368\u201375. https:\/\/doi.org\/10.1161\/01.ATV.0000184769.22061.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"529_CR15","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.chroma.2013.07.026.","volume":"1305","author":"S Salihovic","year":"2013","unstructured":"Salihovic S, K\u00e4rrman A, Lindstr\u00f6m G, Lind PM, Lind L, van Bavel B. A rapid method for the determination of perfluoroalkyl substances including structural isomers of perfluorooctane sulfonic acid in human serum using 96-well plates and column-switching ultra-high performance liquid chromatography tandem mass spectrometry. J Chromatogr A. 2013;1305:164\u201370. https:\/\/doi.org\/10.1016\/j.chroma.2013.07.026.","journal-title":"J Chromatogr A"},{"key":"529_CR16","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.envint.2016.08.002.","volume":"95","author":"J Stubleski","year":"2016","unstructured":"Stubleski J, Salihovic S, Lind L, Lind PM, van Bavel B, Karrman A. Changes in serum levels of perfluoroalkyl substances during a 10-year follow-up period in a large population-based cohort. Environ Int. 2016;95:86\u201392. https:\/\/doi.org\/10.1016\/j.envint.2016.08.002.","journal-title":"Environ Int"},{"key":"529_CR17","doi-asserted-by":"crossref","unstructured":"Fitzmaurice GM, Laird NM, Ware JH. Applied Longitudinal Analysis. John Wiley & Sons; 2012.","DOI":"10.1002\/9781119513469"},{"key":"529_CR18","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1042\/cs0680581.","volume":"68","author":"M Boberg","year":"1985","unstructured":"Boberg M, Croon LB, Gustafsson IB, Vessby B. Platelet fatty acid composition in relation to fatty acid composition in plasma and to serum lipoprotein lipids in healthy subjects with special reference to the linoleic acid pathway. Clin Sci (Lond, Engl: 1979) 1985;68:581\u20137. https:\/\/doi.org\/10.1042\/cs0680581.","journal-title":"Clin Sci (Lond, Engl: 1979)"},{"key":"529_CR19","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/j.jdiacomp.2016.05.001.","volume":"30","author":"B Conway","year":"2016","unstructured":"Conway B, Innes KE, Long D. Perfluoroalkyl substances and beta cell deficient diabetes. J Diabetes Complicat. 2016;30:993\u20138. https:\/\/doi.org\/10.1016\/j.jdiacomp.2016.05.001.","journal-title":"J Diabetes Complicat"},{"key":"529_CR20","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/j.envres.2009.08.002","volume":"109","author":"J MacNeil","year":"2009","unstructured":"MacNeil J, Steenland NK, Shankar A, Ducatman A. A cross-sectional analysis of type II diabetes in a community with exposure to perfluorooctanoic acid (PFOA). Environ Res. 2009;109:997\u20131003. https:\/\/doi.org\/10.1016\/j.envres.2009.08.002.","journal-title":"Environ Res"},{"key":"529_CR21","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.envint.2015.11.016.","volume":"88","author":"TC Su","year":"2016","unstructured":"Su TC, Kuo CC, Hwang JJ, Lien GW, Chen MF, Chen PC. Serum perfluorinated chemicals, glucose homeostasis and the risk of diabetes in working-aged Taiwanese adults. Environ Int. 2016;88:15\u201322. https:\/\/doi.org\/10.1016\/j.envint.2015.11.016.","journal-title":"Environ Int"},{"key":"529_CR22","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s00125-013-3126-3.","volume":"57","author":"L Lind","year":"2014","unstructured":"Lind L, Zethelius B, Salihovic S, van Bavel B, Lind PM. Circulating levels of perfluoroalkyl substances and prevalent diabetes in the elderly. Diabetologia. 2014;57:473\u20139. https:\/\/doi.org\/10.1007\/s00125-013-3126-3.","journal-title":"Diabetologia"},{"key":"529_CR23","doi-asserted-by":"publisher","first-page":"037001","DOI":"10.1289\/EHP2619.","volume":"126","author":"Q Sun","year":"2018","unstructured":"Sun Q, Zong G, Valvi D, Nielsen F, Coull B, Grandjean P. Plasma concentrations of perfluoroalkyl substances and risk of type 2 diabetes: a prospective investigation among U.S. women. Environ Health Perspect. 2018;126:037001. https:\/\/doi.org\/10.1289\/EHP2619.","journal-title":"Environ Health Perspect"},{"key":"529_CR24","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.envint.2018.12.026.","volume":"123","author":"C Donat-Vargas","year":"2019","unstructured":"Donat-Vargas C, Bergdahl IA, Tornevi A, Wennberg M, Sommar J, Kiviranta H, et al. Perfluoroalkyl substances and risk of type II diabetes: a prospective nested case-control study. Environ Int. 2019;123:390\u20138. https:\/\/doi.org\/10.1016\/j.envint.2018.12.026.","journal-title":"Environ Int"},{"key":"529_CR25","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.envres.2012.11.006.","volume":"121","author":"M Fisher","year":"2013","unstructured":"Fisher M, Arbuckle TE, Wade M, Haines DA. Do perfluoroalkyl substances affect metabolic function and plasma lipids?-Analysis of the 2007-2009, Canadian Health Measures Survey (CHMS) cycle 1. Environ Res. 2013;121:95\u2013103. https:\/\/doi.org\/10.1016\/j.envres.2012.11.006.","journal-title":"Environ Res"},{"key":"529_CR26","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1289\/ehp.0901165.","volume":"118","author":"JW Nelson","year":"2010","unstructured":"Nelson JW, Hatch EE, Webster TF. Exposure to polyfluoroalkyl chemicals and cholesterol, body weight, and insulin resistance in the general U.S. population. Environ Health Perspect. 2010;118:197\u2013202. https:\/\/doi.org\/10.1289\/ehp.0901165.","journal-title":"Environ Health Perspect"},{"key":"529_CR27","doi-asserted-by":"publisher","first-page":"97002","DOI":"10.1289\/ehp9200.","volume":"129","author":"JA Goodrich","year":"2021","unstructured":"Goodrich JA, Alderete TL, Baumert BO, Berhane K, Chen Z, Gilliland FD, et al. Exposure to perfluoroalkyl substances and glucose homeostasis in youth. Environ Health Perspect. 2021;129:97002. https:\/\/doi.org\/10.1289\/ehp9200.","journal-title":"Environ Health Perspect"},{"key":"529_CR28","doi-asserted-by":"publisher","first-page":"130486","DOI":"10.1016\/j.chemosphere.2021.130486.","volume":"278","author":"M Zeeshan","year":"2021","unstructured":"Zeeshan M, Zhang YT, Yu S, Huang WZ, Zhou Y, Vinothkumar R, et al. Exposure to isomers of per- and polyfluoroalkyl substances increases the risk of diabetes and impairs glucose-homeostasis in Chinese adults: isomers of C8 health project. Chemosphere. 2021;278:130486. https:\/\/doi.org\/10.1016\/j.chemosphere.2021.130486.","journal-title":"Chemosphere"},{"key":"529_CR29","doi-asserted-by":"publisher","first-page":"702","DOI":"10.2337\/dc08-1816.","volume":"32","author":"CY Lin","year":"2009","unstructured":"Lin CY, Chen PC, Lin YC, Lin LY. Association among serum perfluoroalkyl chemicals, glucose homeostasis, and metabolic syndrome in adolescents and adults. Diabetes Care. 2009;32:702\u20137. https:\/\/doi.org\/10.2337\/dc08-1816.","journal-title":"Diabetes Care"},{"key":"529_CR30","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1289\/ehp303.","volume":"125","author":"AF Fleisch","year":"2017","unstructured":"Fleisch AF, Rifas-Shiman SL, Mora AM, Calafat AM, Ye X, Luttmann-Gibson H, et al. Early-life exposure to perfluoroalkyl substances and childhood metabolic function. Environ Health Perspect. 2017;125:481\u20137. https:\/\/doi.org\/10.1289\/ehp303.","journal-title":"Environ Health Perspect"},{"key":"529_CR31","doi-asserted-by":"publisher","first-page":"107001","DOI":"10.1289\/ehp1612.","volume":"125","author":"A Cardenas","year":"2017","unstructured":"Cardenas A, Gold DR, Hauser R, Kleinman KP, Hivert MF, Calafat AM, et al. Plasma concentrations of per- and polyfluoroalkyl substances at baseline and associations with glycemic indicators and diabetes incidence among high-risk adults in the diabetes prevention program trial. Environ Health Perspect. 2017;125:107001. https:\/\/doi.org\/10.1289\/ehp1612.","journal-title":"Environ Health Perspect"},{"key":"529_CR32","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-022-05695-5","author":"SK Park","year":"2022","unstructured":"Park SK, Wang X, Ding N, Karvonen-Gutierrez CA, Calafat AM, Herman WH. et al. Per- and polyfluoroalkyl substances and incident diabetes in midlife women: the Study of Women\u2019s Health Across the Nation (SWAN). Diabetologia.\u00a02022;65:1157\u201368.\u00a0https:\/\/doi.org\/10.1007\/s00125-022-05695-5.","journal-title":"Diabetologia"},{"key":"529_CR33","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s12940-015-0029-4.","volume":"14","author":"RT Zoeller","year":"2015","unstructured":"Zoeller RT, Vandenberg LN. Assessing dose-response relationships for endocrine disrupting chemicals (EDCs): a focus on non-monotonicity. Environ Health: Glob Access Sci Source. 2015;14:42. https:\/\/doi.org\/10.1186\/s12940-015-0029-4.","journal-title":"Environ Health: Glob Access Sci Source"},{"key":"529_CR34","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/b978-0-12-800095-3.00005-5.","volume":"94","author":"LN Vandenberg","year":"2014","unstructured":"Vandenberg LN. Low-dose effects of hormones and endocrine disruptors. Vitam Horm. 2014;94:129\u201365. https:\/\/doi.org\/10.1016\/b978-0-12-800095-3.00005-5.","journal-title":"Vitam Horm"},{"key":"529_CR35","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/j.ijheh.2018.07.007","volume":"221","author":"FR Mancini","year":"2018","unstructured":"Mancini FR, Rajaobelina K, Praud D, Dow C, Antignac JP, Kvaskoff M, et al. Nonlinear associations between dietary exposures to perfluorooctanoic acid (PFOA) or perfluorooctane sulfonate (PFOS) and type 2 diabetes risk in women: findings from the E3N cohort study. Int J Hyg Environ health. 2018;221:1054\u201360. https:\/\/doi.org\/10.1016\/j.ijheh.2018.07.007","journal-title":"Int J Hyg Environ health"},{"key":"529_CR36","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.envres.2012.03.007.","volume":"116","author":"GB Post","year":"2012","unstructured":"Post GB, Cohn PD, Cooper KR. Perfluorooctanoic acid (PFOA), an emerging drinking water contaminant: a critical review of recent literature. Environ Res. 2012;116:93\u2013117. https:\/\/doi.org\/10.1016\/j.envres.2012.03.007.","journal-title":"Environ Res"},{"key":"529_CR37","doi-asserted-by":"publisher","unstructured":"Lind PM, Lind L, Salihovic S, Ahlstr\u00f6m H, Michaelsson K, Kullberg J, et al. Serum levels of perfluoroalkyl substances (PFAS) and body composition \u2013 a cross-sectional study in a middle-aged population. Environ Res. 2022;209:112677. https:\/\/doi.org\/10.1016\/j.envres.2022.112677.","DOI":"10.1016\/j.envres.2022.112677"},{"key":"529_CR38","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1007\/s00204-020-02715-4.","volume":"94","author":"K Abraham","year":"2020","unstructured":"Abraham K, Mielke H, Fromme H, V\u00f6lkel W, Menzel J, Peiser M, et al. Internal exposure to perfluoroalkyl substances (PFASs) and biological markers in 101 healthy 1-year-old children: associations between levels of perfluorooctanoic acid (PFOA) and vaccine response. Arch Toxicol. 2020;94:2131\u201347. https:\/\/doi.org\/10.1007\/s00204-020-02715-4.","journal-title":"Arch Toxicol"},{"key":"529_CR39","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.envres.2016.10.002.","volume":"152","author":"PM Lind","year":"2017","unstructured":"Lind PM, Salihovic S, van Bavel B, Lind L. Circulating levels of perfluoroalkyl substances (PFASs) and carotid artery atherosclerosis. Environ Res. 2017;152:157\u201364. https:\/\/doi.org\/10.1016\/j.envres.2016.10.002.","journal-title":"Environ Res"},{"key":"529_CR40","doi-asserted-by":"publisher","first-page":"403","DOI":"10.2131\/jts.36.403.","volume":"36","author":"SS Knox","year":"2011","unstructured":"Knox SS, Jackson T, Frisbee SJ, Javins B, Ducatman AM. Perfluorocarbon exposure, gender and thyroid function in the C8 Health Project. J Toxicol Sci. 2011;36:403\u201310. https:\/\/doi.org\/10.2131\/jts.36.403.","journal-title":"J Toxicol Sci"},{"key":"529_CR41","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1289\/ehp.1509869.","volume":"124","author":"M-J Lopez-Espinosa","year":"2016","unstructured":"Lopez-Espinosa M-J, Mondal D, Armstrong BG, Eskenazi B, Fletcher T. Perfluoroalkyl substances, sex hormones, and insulin-like growth factor-1 at 6\u20139 years of age: a cross-sectional analysis within the C8 health project. Environ Health Perspect. 2016;124:1269\u201375. https:\/\/doi.org\/10.1289\/ehp.1509869.","journal-title":"Environ Health Perspect"},{"key":"529_CR42","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.envint.2013.03.008","volume":"57-58","author":"T Fletcher","year":"2013","unstructured":"Fletcher T, Galloway TS, Melzer D, Holcroft P, Cipelli R, Pilling LC, et al. Associations between PFOA, PFOS and changes in the expression of genes involved in cholesterol metabolism in humans. Environ Int. 2013;57-58:2\u201310. https:\/\/doi.org\/10.1016\/j.envint.2013.03.008","journal-title":"Environ Int"},{"key":"529_CR43","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.yrtph.2019.05.008.","volume":"106","author":"DM Pizzurro","year":"2019","unstructured":"Pizzurro DM, Seeley M, Kerper LE, Beck BD. Interspecies differences in perfluoroalkyl substances (PFAS) toxicokinetics and application to health-based criteria. Regul Toxicol Pharmacol. 2019;106:239\u201350. https:\/\/doi.org\/10.1016\/j.yrtph.2019.05.008.","journal-title":"Regul Toxicol Pharmacol"},{"key":"529_CR44","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.toxlet.2016.08.024.","volume":"261","author":"J Tuomisto","year":"2016","unstructured":"Tuomisto J, Airaksinen R, Kiviranta H, Tukiainen E, Pekkanen J, Tuomisto JT. A pharmacokinetic analysis and dietary information are necessary to confirm or reject the hypothesis on persistent organic pollutants causing type 2 diabetes. Toxicol Lett. 2016;261:41\u201348. https:\/\/doi.org\/10.1016\/j.toxlet.2016.08.024.","journal-title":"Toxicol Lett"},{"key":"529_CR45","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1021\/acs.jafc.6b04683.","volume":"65","author":"JL Domingo","year":"2017","unstructured":"Domingo JL, Nadal M. Per- and Polyfluoroalkyl Substances (PFASs) in food and human dietary intake: a review of the recent scientific literature. J Agric Food Chem. 2017;65:533\u201343. https:\/\/doi.org\/10.1021\/acs.jafc.6b04683.","journal-title":"J Agric Food Chem"},{"key":"529_CR46","doi-asserted-by":"publisher","first-page":"e06223","DOI":"10.2903\/j.efsa.2020.6223.","volume":"18","author":"D Schrenk","year":"2020","unstructured":"Chain EPanel oCitF, Schrenk D, Bignami M, Bodin L, Chipman JK, del Mazo J, et al. Risk to human health related to the presence of perfluoroalkyl substances in food. EFSA J. 2020;18:e06223 https:\/\/doi.org\/10.2903\/j.efsa.2020.6223.","journal-title":"EFSA J"},{"key":"529_CR47","doi-asserted-by":"publisher","first-page":"113170","DOI":"10.1016\/j.envres.2022.113170.","volume":"212","author":"J Nystr\u00f6m","year":"2022","unstructured":"Nystr\u00f6m J, Benskin JP, Plassmann M, Sandblom O, Glynn A, Lampa E, et al. Healthy eating index and diet diversity score as determinants of serum perfluoroalkyl acid (PFAA) concentrations in a national survey of Swedish adolescents. Environ Res. 2022;212:113170. https:\/\/doi.org\/10.1016\/j.envres.2022.113170.","journal-title":"Environ Res"},{"key":"529_CR48","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.envres.2016.05.016.","volume":"150","author":"P Sjogren","year":"2016","unstructured":"Sjogren P, Montse R, Lampa E, Salihovic S, van Bavel B, Lind L, et al. Circulating levels of perfluoroalkyl substances are associated with dietary patterns \u2013 a cross sectional study in elderly Swedish men and women. Environ Res. 2016;150:59\u201365. https:\/\/doi.org\/10.1016\/j.envres.2016.05.016.","journal-title":"Environ Res"}],"container-title":["Journal of Exposure Science &amp; Environmental Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41370-023-00529-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41370-023-00529-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41370-023-00529-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T19:05:07Z","timestamp":1696014307000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41370-023-00529-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,24]]},"references-count":48,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["529"],"URL":"https:\/\/doi.org\/10.1038\/s41370-023-00529-x","relation":{},"ISSN":["1559-0631","1559-064X"],"issn-type":[{"value":"1559-0631","type":"print"},{"value":"1559-064X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,24]]},"assertion":[{"value":"20 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}